Onyx Pharmaceuticals, Inc., a Subsidiary of Amgen, Inc.

Form 483

South San Francisco, California, United StatesFEI 3009255166Issued May 17, 2013

View FDA's Record for This Firm

Source: FDA inspection record. Confirmed against FDA's published inspection data for this establishment and inspection date. FDA has published the inspection and what it cited, but not the form itself, which usually takes six to twelve months. To check it, open FDA's record for this establishment on FDA's Data Dashboard, listed under FEI 3009255166.

Observations1

Issue DateMay 17, 2013

StatusNo Warning Letter

Related Inspections3

Establishment Details

Firm: Onyx Pharmaceuticals, Inc., a Subsidiary of Amgen, Inc.
Location: South San Francisco, California, United States
FEI Number: 3009255166
Product Type: Drugs
Issue Date: May 17, 2013
Country: United States

Inspection History, 2012 to 2015

NAI1

VAI2

NAI means No Action Indicated. VAI means Voluntary Action Indicated.

Act on This Form 483

FDA Inspection ReadinessSee how your operations would hold up to the same scrutiny.CAPA & InvestigationsScore how you would investigate and close findings like these.Talk to a SpecialistWalk through these observations with a ComplianceQuest expert.

Onyx Pharmaceuticals, Inc., a Subsidiary of Amgen, Inc. FDA Form 483, South San Francisco, California, May 17, 2013